TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. filed an 8-K with the SEC on June 27, 2024, under ticker MTAC, the original trading symbol of MedTech Acquisition Corp, the blank-check vehicle that brought the company to market. MedTech Acquisition Corp, sponsored by MedTech Acquisition Corp Sponsor, LLC, priced its initial public offering in 2021 with a focus on the healthcare sector. The SPAC completed its business combination with TriSalus Life Sciences, a medical device company developing pressure-enabled drug delivery systems for oncology applications, in 2022. The combined entity operates in the interventional oncology and medical devices space and remains an active public reporting company. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics across the SPAC market.